Parsons PG - Search Results

1

Histone deacetylase inhibitors and malignant melanoma.

Boyle GM, Martyn AC, Parsons PG. Boyle GM, et al. Among authors: parsons pg. Pigment Cell Res. 2005 Jun;18(3):160-6. doi: 10.1111/j.1600-0749.2005.00228.x. Pigment Cell Res. 2005. PMID: 15892712 Review.

2

Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies.

Leonard JH, Marks LH, Chen W, Cook AL, Boyle GM, Smit DJ, Brown DL, Stow JL, Parsons PG, Sturm RA. Leonard JH, et al. Among authors: parsons pg. Pigment Cell Res. 2003 Jun;16(3):198-207. doi: 10.1034/j.1600-0749.2003.00033.x. Pigment Cell Res. 2003. PMID: 12753386

3

Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.

Cozzi SJ, Parsons PG, Ogbourne SM, Pedley J, Boyle GM. Cozzi SJ, et al. Among authors: parsons pg. Cancer Res. 2006 Oct 15;66(20):10083-91. doi: 10.1158/0008-5472.CAN-06-0348. Cancer Res. 2006. PMID: 17047072

4

Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity.

Boyle GM, Pedley J, Martyn AC, Banducci KJ, Strutton GM, Brown DA, Breit SN, Parsons PG. Boyle GM, et al. Among authors: parsons pg. J Invest Dermatol. 2009 Feb;129(2):383-91. doi: 10.1038/jid.2008.270. Epub 2008 Aug 28. J Invest Dermatol. 2009. PMID: 18754039 Free article.

5

H-cadherin expression reduces invasion of malignant melanoma.

Kuphal S, Martyn AC, Pedley J, Crowther LM, Bonazzi VF, Parsons PG, Bosserhoff AK, Hayward NK, Boyle GM. Kuphal S, et al. Among authors: parsons pg. Pigment Cell Melanoma Res. 2009 Jun;22(3):296-306. doi: 10.1111/j.1755-148X.2009.00568.x. Epub 2009 Apr 6. Pigment Cell Melanoma Res. 2009. PMID: 19368692

6

New cysteine derivatives with antiproliferative activity on melanoma cells.

Lucke AJ, Boyle GM, Parsons PG, Fairlie DP. Lucke AJ, et al. Among authors: parsons pg. Med Chem. 2006 Mar;2(2):123-32. doi: 10.2174/157340606776056124. Med Chem. 2006. PMID: 16787361

7

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringnér M, Hayward NK. Pavey S, et al. Among authors: parsons pg. Oncogene. 2004 May 20;23(23):4060-7. doi: 10.1038/sj.onc.1207563. Oncogene. 2004. PMID: 15048078

8

Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.

Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, Gardner JM, Le TT, Lenarczyk A, Aylward JH, Parsons PG. Ogbourne SM, et al. Among authors: parsons pg. Cancer Res. 2004 Apr 15;64(8):2833-9. doi: 10.1158/0008-5472.can-03-2837. Cancer Res. 2004. PMID: 15087400

9

Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.

Glenn MP, Kahnberg P, Boyle GM, Hansford KA, Hans D, Martyn AC, Parsons PG, Fairlie DP. Glenn MP, et al. Among authors: parsons pg. J Med Chem. 2004 Jun 3;47(12):2984-94. doi: 10.1021/jm030222i. J Med Chem. 2004. PMID: 15163181

10

Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid.

Kahnberg P, Lucke AJ, Glenn MP, Boyle GM, Tyndall JD, Parsons PG, Fairlie DP. Kahnberg P, et al. Among authors: parsons pg. J Med Chem. 2006 Dec 28;49(26):7611-22. doi: 10.1021/jm050214x. J Med Chem. 2006. PMID: 17181145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page